ASAP-NORWAY AS
Operating
Neste generasjons høyabsorberende engangslaken – ASAP Norway AS
Neste generasjons oppdekningsutstyr til sengeposter, bord og bårer hvor det er særlige behov i forhold til søl og væskeproblematikk.
Utvikling, produksjon, kjøp og salg av medisinsk utstyr som bl.a.
fuktabsorberende underlag og tilhørende produkter, eie rettigheter i
inn- og utland, eie aksjer i andre selskaper, lisensiering av
produkter og rettigheter, samt hva hermed står i forbindelse.
Utvikling og produksjon av fuktabsorberende underlag.
Keywords
laboratory equipmentlaboratory furnituresurgicalmedicalinstrumentssurgical equipmentdental technologyequipmentorthodonticgoodsdental prosthesesorthodontic appliancestooth fillingsdental cementsadhesivesdental waxplaster preparationslaboratory ovensultrasonic cleaning machineslaboratory sterilization equipmentsyringesneedlescathetersdental chairsartificial teethbridgeshearing aidsglass eyesthermometersvision aidsglasseslensescontact lenses and gogglescardiac pacemakerslaboratory distillation apparatuslaboratory centrifuges
Organization
- CEO
- AK
- Chairman of the board
- KL
- Years since formation
- 19 years
- since Nov 1, 2007
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 15,579,452
- 1 share class
- Total number of shareholders
- 22
- 14 companies, 8 persons
Financials
- Total operating income 2024
- 6,352,281
- NOK
- Annual total result 2024
- -7,845,666
- NOK
- Total equity 2024
- 830,558
- NOK
Last update: Feb 13, 2026
Locations
- Company addressBataljonvegen 30 3734 SKIEN, Norge
Copied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AK | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
KL | Chairman | 47.28 % indirectly |
SC | Board Member | - |
AI | Board Member | 4.89 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
S SKUDAL REVISJON & RÅDGIVNING AS | Auditor | - |
A AIDER AS | Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KL | Chairman | 47.28 % indirectly |
| - | 13.21 % indirectly | |
JG | - | 5.26 % indirectly |
TD | - | 5.26 % indirectly |
AB 1985 | - | 4.89 % indirectly |
AI | Board Member | 4.89 % indirectly |
| - | 4.89 % indirectly | |
KM | - | 2.92 % indirectly |
AH 1984 | - | 2.77 % directly |
PL 1948 | - | 1.89 % directly |
Last update: May 21, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
M MEDTECH INVEST AS | Ordinary shares | 7,265,278 | 46.63 % |
B BRUNVOLL INVEST AS | Ordinary shares | 2,286,444 | 14.68 % |
B BATJAK AS | Ordinary shares | 2,059,556 | 13.22 % |
G GIERTSEN OG CO AS | Ordinary shares | 1,640,499 | 10.53 % |
L LAKESIDE AS | Ordinary shares | 454,428 | 2.92 % |
AH 1984 | Ordinary shares | 431,287 | 2.77 % |
PL 1948 | Ordinary shares | 295,015 | 1.89 % |
G GRENLAND FINANS AS | Ordinary shares | 228,094 | 1.46 % |
M MOTALA AS | Ordinary shares | 193,966 | 1.25 % |
CE | Ordinary shares | 146,861 | 0.94 % |
H HAITOUKIN AS | Ordinary shares | 112,047 | 0.72 % |
B BLIKI AS | Ordinary shares | 105,461 | 0.68 % |
L LAÅ HOLDING AS | Ordinary shares | 105,055 | 0.67 % |
U UNIQON HOLDING AS | Ordinary shares | 101,034 | 0.65 % |
PA | Ordinary shares | 42,082 | 0.27 % |
S SVELOE AS | Ordinary shares | 35,482 | 0.23 % |
M MBLAISE AS | Ordinary shares | 19,181 | 0.12 % |
AK | Ordinary shares | 16,393 | 0.11 % |
ET 1953 | Ordinary shares | 15,708 | 0.1 % |
| Ordinary shares | 10,870 | 0.07 % | |
T TM HOLDING AS | Ordinary shares | 7,616 | 0.05 % |
| Ordinary shares | 7,095 | 0.05 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 6,352,281 | 6,406,630 | 7,689,373 | 9,066,691 |
Annual Total Result | -7,845,666 | -6,048,163 | -6,564,216 | -7,069,260 |
Total assets | 9,922,397 | 13,220,198 | 13,995,657 | 15,097,037 |
Total liabilities | 9,091,839 | 9,543,975 | 9,129,167 | 20,187,100 |
Total equity | 830,558 | 3,676,224 | 4,866,490 | -5,090,064 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 6,352,281 | 6,406,630 | 7,689,373 | 9,066,691 |
Total operating costs | 13,615,603 | 11,742,947 | 12,967,301 | 15,385,038 |
Operating result | -7,263,323 | -5,336,317 | -5,277,927 | -6,318,347 |
Financial income/costs | -582,344 | -711,846 | -1,286,289 | -750,913 |
Profit before tax | -7,845,666 | -6,048,163 | -6,564,216 | -7,069,260 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -7,845,666 | -6,048,163 | -6,564,216 | -7,069,260 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 5,018,691 | 6,390,815 | 7,832,394 | 9,256,367 |
Total current assets | 4,903,706 | 6,829,384 | 6,163,263 | 5,840,670 |
Total assets | 9,922,397 | 13,220,198 | 13,995,657 | 15,097,037 |
Short term debt | 1,609,425 | 2,061,561 | 2,066,722 | 4,604,985 |
Long term debt | 7,482,414 | 7,482,414 | 7,062,444 | 15,582,115 |
Total liabilities | 9,091,839 | 9,543,975 | 9,129,167 | 20,187,100 |
Contributed capital | 51,281,689 | 46,281,689 | 39,580,439 | 33,563,369 |
Retained earnings | -50,451,132 | -42,605,465 | -34,713,949 | -38,653,433 |
Total equity | 830,558 | 3,676,224 | 4,866,490 | -5,090,064 |
Total equity and liabilities | 9,922,397 | 13,220,198 | 13,995,657 | 15,097,037 |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
32
Activity
Other manufacturing
32.5
Main industrial group
Manufacture of medical and dental instruments and supplies
32.50
Industrial group
Manufacture of medical and dental instruments and supplies
32.500
Industrial group
Manufacture of medical and dental instruments and supplies